Advertisement
Screener

CORE LABORATORIES N.V. Form 8-K: Current report, 2019

CORE LABORATORIES N.V. Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2019-12-30: Form 8-K; Period of report 2019-12-30; Description 7.01 Regulation FD Disclosure; Details 7.01.
  • 2019-10-23: Form 8-K; Period of report 2019-10-23; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
  • 2019-10-08: Form 8-K; Period of report 2019-10-08; Description 7.01 Regulation FD Disclosure; Details 7.01.
  • 2019-07-24: Form 8-K; Period of report 2019-07-24; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
FiledFormPeriod of reportDescriptionDetailsDocument
2019-12-308-K2019-12-307.01 Regulation FD Disclosure7.01 On December 30, 2019, Core Laboratories N.V. issued a press release announcing revisions to previously issued earnings guidance for its 2019 fourth quarter, initial guidance for 2020 first quarter and a reduction of the quarterly dividend.clb-8k_20191230.htm
2019-10-238-K2019-10-232.02 Results of Operations and Financial Condition2.02 On October 23, 2019, Core Laboratories N.V. (the "Company") issued a press release announcing its financial results for the third quarter of 2019.clb-8k_20191023.htm
2019-10-088-K2019-10-087.01 Regulation FD Disclosure7.01 On October 8, 2019, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on October 18, 2019 and payable November 19, 2019.clb-8k_20191008.htm
2019-07-248-K2019-07-242.02 Results of Operations and Financial Condition2.02 On July 24, 2019, Core Laboratories N.V. (the "Company") issued a press release announcing its financial results for the second quarter of 2019.clb-8k_20190724.htm
2019-07-128-K2019-07-127.01 Regulation FD Disclosure7.01 On July 12, 2019, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on July 22, 2019 and payable August 12, 2019.clb-8k_dividend3q2019.htm
2019-05-298-K2019-05-295.07 Submission of Matters to a Vote of Security Holders5.07 Core Laboratories N.V. (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting") on May 23, 2019 in Amsterdam, the Netherlands.a2019annualshareholdermeet.htm
2019-04-248-K2019-04-242.02 Results of Operations and Financial Condition2.02 On April 24, 2019, Core Laboratories N.V. (the "Company") issued a press release announcing its financial results for the first quarter of 2019.clb-8k_20190424.htm
2019-04-168-K2019-04-167.01 Regulation FD Disclosure7.01 On April 16, 2019, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on April 26, 2019 and payable May 21, 2019.clb-8k_dividend2q2019.htm
2019-03-068-K2019-03-015.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 On March 1, 2019, Core Laboratories N.V. (the “Company”) entered into employment agreements (the “Employment Agreements”) with two of its named executive officers, Mr. Lawrence V. Bruno, the Company’s President and Chief Operating Officer, and Mr. Christopher S. Hill, the Company’s Senior Vice President and Chief Financial Officer.d712401d8k.htm
2019-01-308-K2019-01-302.02 Results of Operations and Financial Condition2.02 On January 30, 2019, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2018 and the year ending December 31, 2018.clb-2018q4_earningsrelease.htm
2019-01-158-K2019-01-157.01 Regulation FD Disclosure7.01 On January 15, 2019, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on January 25, 2019 and payable February 15, 2019.clb-8k_dividend1q2019.htm